Good post, but I have a thought. I am not sur
Post# of 148190
I am not sure that Leronlimab itself is on complete lockdown hold by the FDA. Specific clinical trials are on hold, but if CYDY had the money, could they be doing a NASH trial right now? Here is the relevant wording from the press release:
"...FDA has placed a partial clinical hold on its HIV program and a full clinical hold on its COVID-19 program in the United States. Further, the Company elected to pause its Brazil COVID-19 trials..."
It does not say that all trials involving Leronlimab are on hold in the United States.
Still wondering what happened to all of the oncology talk from months ago as that was to be CYDY's main focus, but as we know, was never mentioned in the latest CC.